Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans. Nussbaumer-Proll A, Matzneller P, Eberl S, Zeitlinger M, et al. Eur J Clin Microbiol Infect Dis 2024 Mar 14. doi: 10.1007/s10096-024-04799.

Read + Share

Amedeo Smart

Independent Medical Education

Nussbaumer-Proll A, Matzneller P, Eberl S, Zeitlinger M, et al. Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans. Eur J Clin Microbiol Infect Dis 2024 Mar 14. doi: 10.1007/s10096-024-04799.
PMID: 38483681